Founded in 2021, Alcanza Clinical Research’s platform conducts clinical trials across phases I-IV in various therapeutic areas, including vaccines, neurology, psychiatry, metabolic and dermatology. Alcanza focuses on promoting inclusivity within its staff and diverse patient populations from communities surrounding its sites to provide high-quality research opportunities. With a network of locations across the U.S. including Puerto Rico, Alcanza is dedicated to reducing barriers to clinical trial participation while maintaining a strong emphasis on patient care and data integrity.